Cited by 81Sphingolipid Metabolism and SignalingNeuroinflammation and Neurodegeneration MechanismsLysosomal Storage Disorders Research

Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy

Open access
Lee, Ju Youn, Jin, Hee Kyung, Bae, Jae-sung·2020·BMB Reports

Abstract

Sphingolipids are ubiquitous building blocks of eukaryotic cell membranes that function as signaling molecules for regulating a diverse range of cellular processes, including cell proliferation, growth, survival, immune-cell trafficking, vascular and epithelial integrity, and inflammation. Recently, several studies have highlighted the pivotal role of sphingolipids in neuroinflammatory regulation. Sphingolipids have multiple functions, including induction of the expression of various inflammatory mediators and regulation of neuroinflammation by directly effecting the cells of the central nervous system. Accumulating evidence points to sphingolipid engagement in neuroinflammatory disorders, including Alzheimer's and Parkinson's diseases. Abnormal sphingolipid alterations, which involves an increase in ceramide and a decrease in sphingosine kinase, are observed during neuroinflammatory disease. These trends are observed early during disease development, and thus highlight the potential of sphingolipids as a new therapeutic and diagnostic target for neuroinflammatory diseases. [BMB Reports 2020; 53(1): 28-34].

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5483/bmbrep.2020.53.1.278

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Ceramides are bioactive sphingolipids involved in cell signaling, apoptosis, and membrane structure, and play a critical role in neurodegenerative diseases like Alzheimer's disease.

    “Cers are bioactive sphingolipids involved in cell signaling, apoptosis, and membrane structure, playing a critical role in neurodegenerative diseases like AD. 22 , 23”

    From Protective mechanisms against Alzheimer's disease in APOE3‐Christchurch homozygous astrocytes (2025) · cites this paper as [23]

    The Ceramide section describes ceramide’s effects on neuronal cell death, apoptosis, and inflammatory signaling. The Alzheimer’s disease section links altered ceramide levels and metabolism to AD pathogenesis. The cited passages do not establish the claimed role of ceramides in membrane structure. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Abnormal sphingolipid levels are linked to neuroinflammatory disorders.

    “These abnormal changes in sphingolipid levels have been closely linked to neuroinflammatory disorders, as they play a crucial role in cell signaling and are, therefore, frequently discussed as potential therapeutic targets (45, 46).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, J. Y., Jin, H. K., & Bae, J.-S.
Affiliations
Kyungpook National University (KR)
Corresponding author
Lee, Ju Youn
Venue
BMB Reports
Published
2020-01-31
Volume
53
Issue
1
Pages
28-34
ISSN
  • 1976-6696 (ISSN-L)
  • 1976-670X
OpenAlex
W2997449152
Cited by
80
References
64
Citations by year
2026: 6 · 2025: 19 · 2024: 15 · 2023: 12 · 2022: 16 · 2021: 9 · 2020: 2 · 2019: 1
FWCI
3.16
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • BMB Reports (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • National Research Foundation of Korea (2017R1A4A1015652, 2018M3C7A1056513)
  • Ministry of Science ICT and Future Planning
  • Korea Health Industry Development Institute
  • Ministry of Health and Welfare (HI16C2131)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Physiology › Lysosomal Storage Disorders Research
Keywords
sphingolipids, neuroinflammation, ceramide, sphingosine kinase, Alzheimer's disease, Parkinson's disease, inflammatory mediators, therapeutic target, diagnostic biomarkers, central nervous system
MeSH terms
Sphingosine Kinase, Alzheimer Disease, Central Nervous System, Ceramides, Humans, Inflammation, Lysophospholipids, Parkinson Disease, Sphingolipids, Sphingosine, Signal Transduction, Microglia, Phosphotransferases (Alcohol Group Acceptor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review